POTENTIAL AND LIMITATIONS OF DRUG TARGETING - AN OVERVIEW

[1] ALVING CR, 1982, DRUG TARGETING, P337

[2] DELIVERY OF A QUATERNARY PYRIDINIUM SALT ACROSS BLOOD-BRAIN-BARRIER BY ITS DIHYDROPYRIDINE DERIVATIVE [J]. SCIENCE, 1975, 190 (4210) : 155 - 156

[3] BODOR N, 1983, EUR J MED CHEM, V18, P235

[4] REDOX DELIVERY SYSTEM FOR BRAIN-SPECIFIC, SUSTAINED-RELEASE OF DOPAMINE [J]. SCIENCE, 1983, 221 (4605) : 65 - 67

[5] SINEMET AND THE TREATMENT OF PARKINSONISM [J]. ANNALS OF INTERNAL MEDICINE, 1981, 94 (03) : 364 - 370

[6] (-) BACLOFEN DECREASES NEUROTRANSMITTER RELEASE IN THE MAMMALIAN CNS BY AN ACTION AT A NOVEL GABA RECEPTOR [J]. NATURE, 1980, 283 (5742) : 92 - 94

[7] Breimer DD, 1983, TOP PHARM SCI, P305

[8] BURCHALL JJ, 1965, MOL PHARMACOL, V1, P126

[9] BURCHALL JJ, 1971, ANN NY ACAD SCI, V186, P143

[10] PLASMIN-ACTIVATED PRODRUGS FOR CANCER-CHEMOTHERAPY .1. SYNTHESIS AND BIOLOGICAL-ACTIVITY OF PEPTIDYLACIVICIN AND PEPTIDYLPHENYLENEDIAMINE MUSTARD [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (05) : 633 - 638

[1] ALVING CR, 1982, DRUG TARGETING, P337

[2] DELIVERY OF A QUATERNARY PYRIDINIUM SALT ACROSS BLOOD-BRAIN-BARRIER BY ITS DIHYDROPYRIDINE DERIVATIVE [J]. SCIENCE, 1975, 190 (4210) : 155 - 156

[3] BODOR N, 1983, EUR J MED CHEM, V18, P235

[4] REDOX DELIVERY SYSTEM FOR BRAIN-SPECIFIC, SUSTAINED-RELEASE OF DOPAMINE [J]. SCIENCE, 1983, 221 (4605) : 65 - 67

[5] SINEMET AND THE TREATMENT OF PARKINSONISM [J]. ANNALS OF INTERNAL MEDICINE, 1981, 94 (03) : 364 - 370

[6] (-) BACLOFEN DECREASES NEUROTRANSMITTER RELEASE IN THE MAMMALIAN CNS BY AN ACTION AT A NOVEL GABA RECEPTOR [J]. NATURE, 1980, 283 (5742) : 92 - 94

[7] Breimer DD, 1983, TOP PHARM SCI, P305

[8] BURCHALL JJ, 1965, MOL PHARMACOL, V1, P126

[9] BURCHALL JJ, 1971, ANN NY ACAD SCI, V186, P143

[10] PLASMIN-ACTIVATED PRODRUGS FOR CANCER-CHEMOTHERAPY .1. SYNTHESIS AND BIOLOGICAL-ACTIVITY OF PEPTIDYLACIVICIN AND PEPTIDYLPHENYLENEDIAMINE MUSTARD [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (05) : 633 - 638